Literature DB >> 21282716

Voriconazole as secondary antifungal prophylaxis in stem cell transplant recipients.

Catherine Cordonnier, Montserrat Rovira, Johan Maertens, Oliver A Cornely, Per Ljungman, Hermann Einsele.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21282716      PMCID： PMC3031680          DOI： 10.3324/haematol.2010.038463

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  10 in total

1.  Prophylaxis of invasive fungal diseases in patients with hematologic disorders.

Authors:  Corrado Girmenia
Journal:  Haematologica       Date:  2010-10       Impact factor: 9.941

Review 2.  Clinical issues regarding relapsing aspergillosis and the efficacy of secondary antifungal prophylaxis in patients with hematological malignancies.

Authors:  Nikolaos V Sipsas; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2006-04-24       Impact factor: 9.079

3.  Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.

Authors:  Rodrigo Martino; Rocio Parody; Takahiro Fukuda; Johan Maertens; Koen Theunissen; Aloysius Ho; Ghulam J Mufti; Nicolaus Kroger; Arnold R Zander; Dominik Heim; Monika Paluszewska; Dominik Selleslag; Katerina Steinerova; Per Ljungman; Simone Cesaro; Anna Nihtinen; Catherine Cordonnier; Lourdes Vazquez; Monica López-Duarte; Javier Lopez; Rafael Cabrera; Montserrat Rovira; Stefan Neuburger; Oliver Cornely; Ann E Hunter; Kieren A Marr; Hans Jürgen Dornbusch; Hermann Einsele
Journal:  Blood       Date:  2006-05-23       Impact factor: 22.113

4.  Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.

Authors:  Marcie Tomblyn; Tom Chiller; Hermann Einsele; Ronald Gress; Kent Sepkowitz; Jan Storek; John R Wingard; Jo-Anne H Young; Michael J Boeckh; Michael A Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2009-10       Impact factor: 5.742

5.  Prophylaxis and treatment of invasive fungal diseases in allogeneic stem cell transplantation: results of a consensus process by Gruppo Italiano Trapianto di Midollo Osseo (GITMO).

Authors:  Corrado Girmenia; Giovanni Barosi; Franco Aversa; Andrea Bacigalupo; Tiziano Barbui; Donatella Baronciani; Alberto Bosi; Anna Candoni; Anna Locasciulli; Franco Locatelli; Francesco Menichetti; Maurizio Musso; Claudio Viscoli; Alessandro Rambaldi
Journal:  Clin Infect Dis       Date:  2009-10-15       Impact factor: 9.079

6.  Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation.

Authors:  John R Wingard; Shelly L Carter; Thomas J Walsh; Joanne Kurtzberg; Trudy N Small; Lindsey R Baden; Iris D Gersten; Adam M Mendizabal; Helen L Leather; Dennis L Confer; Richard T Maziarz; Edward A Stadtmauer; Javier Bolaños-Meade; Janice Brown; John F Dipersio; Michael Boeckh; Kieren A Marr
Journal:  Blood       Date:  2010-09-08       Impact factor: 22.113

7.  European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update.

Authors:  J Maertens; O Marchetti; R Herbrecht; O A Cornely; U Flückiger; P Frêre; B Gachot; W J Heinz; C Lass-Flörl; P Ribaud; A Thiebaut; C Cordonnier
Journal:  Bone Marrow Transplant       Date:  2010-07-26       Impact factor: 5.483

8.  Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study.

Authors:  Catherine Cordonnier; Montserrat Rovira; Johan Maertens; Eduardo Olavarria; Catherine Faucher; Karin Bilger; Arnaud Pigneux; Oliver A Cornely; Andrew J Ullmann; Rodrigo Martino Bofarull; Rafael de la Cámara; Maja Weisser; Effie Liakopoulou; Manuel Abecasis; Claus Peter Heussel; Marc Pineau; Per Ljungman; Hermann Einsele
Journal:  Haematologica       Date:  2010-07-15       Impact factor: 9.941

9.  Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant center.

Authors:  Takahiro Fukuda; Michael Boeckh; Katherine A Guthrie; Debra K Mattson; Stephanie Owens; Anna Wald; Brenda M Sandmaier; Lawrence Corey; Rainer F Storb; Kieren A Marr
Journal:  Biol Blood Marrow Transplant       Date:  2004-07       Impact factor: 5.742

10.  Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation.

Authors:  Pierre-Yves Bochud; Jason W Chien; Kieren A Marr; Wendy M Leisenring; Arlo Upton; Marta Janer; Stephanie D Rodrigues; Sarah Li; John A Hansen; Lue Ping Zhao; Alan Aderem; Michael Boeckh
Journal:  N Engl J Med       Date:  2008-10-23       Impact factor: 91.245
  10 in total
  5 in total

Review 1.  Fungal infections in children with haematologic malignancies and stem cell transplant recipients.

Authors:  William R Otto; Abby M Green
Journal:  Br J Haematol       Date:  2020-03-11       Impact factor: 6.998

2.  Voriconazole and its clinical potential in the prophylaxis of systemic fungal infection in patients with hematologic malignancies: a perspective review.

Authors:  Amaya Zabalza; Ana Gorosquieta; Encarnación Pérez Equiza; Eduardo Olavarria
Journal:  Ther Adv Hematol       Date:  2013-06

Review 3.  Foiling fungal disease post hematopoietic cell transplant: review of prophylactic strategies.

Authors:  S M Rubinstein; K A Culos; B Savani; G Satyanarayana
Journal:  Bone Marrow Transplant       Date:  2017-10-23       Impact factor: 5.483

Review 4.  Epidemiology of invasive fungal diseases on the basis of autopsy reports.

Authors:  María Cecilia Dignani
Journal:  F1000Prime Rep       Date:  2014-09-04

5.  Systemic Antifungal Prophylaxis in Patients Hospitalized in Hematology Units in France: The AFHEM Cross-Sectional Observational Study.

Authors:  Jean-Pierre Gangneux; Jean El Cheikh; Raoul Herbrecht; Ibrahim Yakoub-Agha; Jean-Baptiste Quiniou; Denis Caillot; Mauricette Michallet
Journal:  Infect Dis Ther       Date:  2018-06-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.